Medium Dose DCSZ11 + Standard Treatment for squamous cell carcinoma of head and neck

A treatment and a condition, followed through the public trial records. Not medical advice. How a status is set

Phase 1 trial. Early trial in people, checking safety. As of 19 Nov 2026, from 1 registered trial.

Why this status

  1. 25 Jun 2025: Trial registered, NCT07035249
  2. 16 Dec 2025: Trial started, NCT07035249

The trials

NCT07035249: DCSZ11 in Combination With Standard Therapy in Advanced or Metastatic Solid Tumors

State
Under way
Phase
Phase 1 and Phase 2
People
9 planned
Started
16 Dec 2025
Primary completion
1 Jun 2027
Arms
Medium Dose
Results
None posted
  1. 25 Jun 2025: Trial registered
  2. 16 Dec 2025: Trial started

How the status changed

  1. 19 Nov 2026: First set: Phase 1 trial

Registries searched: ClinicalTrials.gov, through 17 Nov 2026.